Background Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute
respiratory syndrome-coronavirus-2. Consensus suggestions can standardise care, thereby …

Importance In December 2019, a novel coronavirus (severe acute respiratory syndrome
coronavirus 2 [SARS-CoV-2]) emerged in China and has spread globally, creating a pandemic. …

We describe the first case of acute cardiac injury directly linked to myocardial localization of
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in a 69‐year‐old patient …

The 2020 International Web Scientific Event in COVID-19 pandemic in critically ill patients
aimed at updating the information and knowledge on the COVID-19 pandemic in the intensive …

Background Antibiotics may be indicated in patients with COVID-19 due to suspected or
confirmed bacterial superinfection. Objectives To investigate antibiotic prescribing practices in …

Objectives Beginning in December 2019, the 2019 novel coronavirus disease (COVID-19)
has caused a pneumonia epidemic that began in Wuhan, China, and is rapidly spreading …

Patients with COVID-19 present a broad spectrum of clinical presentation. Whereas hypoxaemia
is the marker of severity, different strategies of management should be customised to …

OBJECTIVES After cardiac arrest, a key factor determining survival outcomes is low-flow
duration. Our aims were to determine the relation of survival and low-flow duration of …

Background Current management practices and outcomes in weaning from invasive
mechanical ventilation are poorly understood. We aimed to describe the epidemiology, …

Extracorporeal life support (ECLS) was developed more than 50 years ago, initially with
venoarterial and subsequently with venovenous configurations. As the technique of ECLS …